NCT03451292: An ongoing trial by Grifols Therapeutics LLC
This trial is ongoing. It must report results 1 year, 2 months from now.
Full data
Full entry on ClinicalTrials.gov | NCT03451292 |
---|---|
Title | Prevention of Mortality With Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites |
Results Status | Ongoing |
ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
Start date | July 24, 2018 |
Completion date | May 31, 2024 |
Required reporting date | May 31, 2025, midnight |
Actual reporting date | None |
Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
Days late | None |